Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 273–280 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Allena Pharmaceuticals Inc. Reloxaliase (ALLN-177) - (URIROX-2) Enteric Hyperoxaluria Phase 3 Oral Gastroenterology
Allena Pharmaceuticals Inc. ALLN-346-202 Gout in chronic kidney disease (CKD) Phase 2a Oral N/A
Allena Pharmaceuticals Inc. Reloxaliase ALLN-177 (URIROX-1) Enteric Hyperoxaluria Phase 3 Oral Gastroenterology
Allogene Therapeutics Inc. ALLO-501/501A + ALLO-647 - (ALPHA2) Large B-cell lymphoma Phase 2 Data Released intravenous Oncology
Allogene Therapeutics Inc. Cemacabtagene ansegedleucel (cema-cel) (ALPHA3) Large B-Cell Lymphoma (LBCL) Phase 2 Ongoing Intravenous Oncology
Alnylam Pharmaceuticals Inc. Nucresiran (ALN-TTRsc04) - (TRITON-CM) ATTR amyloidosis Phase 3 Ongoing Subcutaneous Genetic Disorder
Alnylam Pharmaceuticals Inc. OXLUMO (lumasiran) - ILLUMINATE-B Primary Hyperoxaluria Type 1 Phase 3 Trial Completed Subcutaneous Genetic Disorder
Alnylam Pharmaceuticals Inc. Vutrisiran - (HELIOS-A) ATTR Amyloidosis Phase 3 Data Released Subcutaneous Genetic Disorder